Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center

  • Klaudia Farkas, Mariann Rutka, Tamás Ferenci, Ferenc Nagy, Anita Bálint, Renáta Bor, Ágnes Milassin, Anna Fábián, Kata Szántó, Zsuzsanna Végh, Zsuzsanna Kürti, Péter L. Lakatos, Zoltán Szepes, Tamás Molnár
  • Expert Opinion on Biological Therapy, August 2017, Taylor & Francis
  • DOI: 10.1080/14712598.2017.1363885

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/14712598.2017.1363885